Oxurion/Investors/News/ThromboGenics Presenting THR-687 Preclinical Data at Euro…

ThromboGenics Presenting THR-687 Preclinical Data at European Association for Vision and Eye Research (EVER) Meeting

27 Sep 2017General

Documents